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CLINICAL INVESTIGATION
Expression of CR1 (CD3S) mRNA in podocytes from adult and
fetal human kidneys
MARIE-DOMINIQUE APPAY, MICHEL D. KAZATCHKINE, MATTHIEU LEVI-STRAUSS,
NICOLE HINGLAIS, and JEAN BARIETY
INSERM U28, Hôpital Broussais, and INSERM U276, Institut Pasteur, Paris, France
Expression of CR1 (CD35) mRNA in podocytes from adult and fetal
human kidneys. The presence of CR! mRNA in podocytes was inves
tigated using a 35S-labeled CR1 cDNA probe and in situ hybridization in
sections from fetal and adult human kidneys. CR! mRNA was only
detected in immature podocytes at early stages of glomerular differen-
tiation in the fetal kidney. In contrast, CR! antigen was abundantly
expressed on immature and mature podocytes in fetal kidneys and adult
glomeruli. Thus, the expression of the CR! gene in podocytes is tightly
regulated. It is possible that the prolonged life span of adult podocytes
is associated with a slow turnover of CR! and low or intermittent
accumulation of CR1 mRNA transcripts.
The human complement receptor type 1 (CR1, CD35) is a
polymorphic single chain membrane glycoprotein expressed on
human erythrocytes, neutrophils, monocytes/macrophages, B
lymphocytes, a subset of CD4+ T lymphocytes, follicular
dendritic cells, KUpifer cells and human adult and fetal
podocytes [1—12]. By immunoelectron microscopy, CR! anti-
gen has been observed on the plasma membrane, in coated pits
[13] and in the Golgi apparatus [6] of adult podocytes. The
number of CR! molecules expressed in adult podocytes has
been estimated to be 2. lO per cell [14]. Using in situ hybrid-
ization, we have now examined the presence of specific CR!
mRNA in podocytes from adult and fetal human kidneys. CR!
mRNA-containing podocytes were present in immature glomer-
uli from fetal kidney, whereas no CR1 mRNA-containing
podocytes were detected in adult kidney sections. This is the
first example, in the human kidney, of the presence of a specific
mRNA in cells during ontogenesis which becomes undectect-
able in normal mature glomeruli, although the antigenic expres-
sion of the gene product persists.
Methods
Tissues
Normal adult kidney tissue specimens were obtained from
normal parts from two kidneys immediately after surgical
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nephrectomy for renal cell carcinoma. Human fetal kidneys
were obtained from 20 and 26 week pregnancies according to
the guidelines of the French National Committee of Ethics.
Tonsil tissues were obtained following elective surgery. Tissue
specimens were immediately quick-frozen and stored in liquid
nitrogen until sectioned.
The 0.75 kb CR!-! cDNA probe from human tonsil [15] was
from D.T. Fearon (Johns Hopkins Medical School, Baltimore,
Maryland, USA). The insert was excised from the plasmid
using Eco R! (Appligene, Illkirch, France) and isolated by
electrophoresis prior to labeling. For in situ hybridization, the
CR! cDNA was labeled with 35S dCTP (Amersham, Les Ulis,
France) using random oligonucleotides as primers to a specific
activity of 0.9 to 2.10° cpmIg. The labeled probe was ethanol-
precipitated and resuspended at 10 pg/ml in 10 mtvt Tris-HCL,!
mM EDTA, pH 7.5. Controls were a 0.9 kb fragment of the
recombinant plasmid, and a renin cDNA (from Dr. P. Corvol,
INSERM U36, Paris, France) labeled to the same specific
activity.
In situ hybridization
In situ hybridization was performed as previously reported
[161 with minor modifications. Briefly, frozen tissue sections
fixed in 3.7% paraformaldehyde in phosphate buffer saline
(PBS) were sequentially digested with 0.2 N HC1 and 10 g/ml
proteinase K for 30 minutes at 37°C. After dehydration and
air-drying, "S-labeled CR! cDNA probe (106 cpmlslide) in 15 d
of hybridization mixture was applied to sections. The hybrid-
izing mixture contained: 50% Dowex AG deionized formamide,
10% dextran, 10 mrs Tris pH 7.4, 1 mM EDTA, NaCI 0.6 N, lx
Denhardt solution, 10 mr'i DTI', yeast tRNA (10 mglml),
sheared salmon sperm cDNA (400 sg/ml), and herring sperm
DNA (400 pg/m1). The sections were covered with siliconized
glass coverslips and sealed. The slides were incubated, for 18
hours at 37°C, de-coverslipped and washed in a solution con-
taining 50% formamide and 50% 8 x SSC for 15 minutes at 20°C,
twice in 2 x SSC for 30 minutes at 20°C and in 2 x SSC for 24
hours at 20°C under gentle agitation. Slides were dehydrated in
graded alcohols before being dipped into a 50% NTB2 emulsion
(Kodak) in water. Autoradiography was for two weeks (human
tonsils) and eight weeks (kidneys) in the dark at 4°C. Autora-
diographies were developed in Kodak D19 (1.5 to 3 minutes,
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Fig. 1. In situ hybridization with the 35S CR1-I DNA probe of a human fetal kidney section (20 gestation weeks). Hybridizing cells are present
at the periphery of an immature glomerulus at the open glomerulus maturation stage. (x 500)
Fig. 2. immunoperoxidase detection of CR! antigen in a semithin section of a human fetal kidney using Fab'2 rabbit anti-CR! antibodies and
peroxidase-labeled Fab'2 sheep anti-rabbit antibodies. The podocyte membrane is stained by the reaction product of peroxidase labeled second
antibody (x 500). The glomerulus is at the same stage of differentiation as that shown in Fig. I. Similar results were obtained using the monoclonal
anti-CR 1 antibody J3D3 [201 (Data not shown).
Fig. 3. In situ hybridization with the CR] cDNA CR1-I probe of an adult human kidney section. No mRNA-containing cell is detectable in the
glomerulus. (x 250). Insert: detailed view of the same glomerulus (X 500).
Fig. 4. Indirect immunofluorescence detection of CR! antigen in a cryostat section of a human adult kidney using Fab'2 rabbit anti-CR]
antibodies and FITC-labeled sheep anti-rabbit antibodies. The CR1 antigen is detected in all the podocytes of the glomerulus (x 250).
20°C) and fixed in Kodak rapid fix for five minutes (20°C). As a
final step, the slides were stained with hematoxylin and eosin.
Negative control experiments included 1) pretreatment with
RNase A (Sigma) at a concentration of 40 g/ml in 2xSSC for
30 minutes at 37°C prior hybridization, 2) hybridization of some
slides with 35S-labeled recombinant plasmid, 3) hybridization of
some slides with MS-labeled renin cDNA.
A positive control experiment was performed by incubating
frozen sections of human tonsils with CR1 cDNA probe [15].
Quantitation of in situ hybridization signal by image analysis
Image analysis was performed on CR! probe-hybridized
sections from two fetal kidneys and two adult kidneys, and on
one RNase A-treated fetal kidney section. We used a computer
vision image processor (NS 1500, Nachet-Vision, France),
designed according to the "mathematical morphology" theory
[17]. Silver grains segmentation was easy at the magnification
x 100. Silver grains were isolated by "top hat" transformation,
to select them according to their size and contrast [18, 19].
Because of the silver grain image overlapping, their surface
rather than their absolute number was calculated. For silver
grains localization, the operator displaced a circular mask upon
immature glomerular structures, mature glomerular structures
and tubular structures. The results were expressed per area unit
(100 m2). Five measurements were performed on twenty
immature glomeruli, on ten mature glomeruli from fetal kidneys
and five measurements were performed on ten glomeruli of
adult kidney. A Newman-Keuls test was performed in a one
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way analysis of variance on measurements. Results were pre-
sented as histograms.
Immunohistochemistry
Alternate cryostat sections of specimens were air dried and
acetone fixed for 10 minutes at room temperature for the
detection of CR1 antigen by indirect immunofluorescence,
using mouse monoclonal or polyclonal rabbit antibodies against
CR1 [6, 20]. The second antibody was either goat anti-mouse
fluoresceinated antibody or sheep anti-rabbit fluoresceinated
antibody (Biosys, Compiegne, France). Some fetal kidney
specimens were stained with Fab'2 anti-CR1 polyclonal anti-
bodies [61 followed by peroxidase-labeled Fab'2 sheep anti-
rabbit IgG, and processed for immunoelectron microscopy as
previously described [1!].
Results
Fetal and adult human kidneys
CR1 mRNA-containing cells were detected in immature
glomeruli from fetal kidneys from the stage of open glomerulus
to that of plunlobulated glomerulus. No hybridizing cells were
detected in fully lobulated glomeruli, that is, in the most mature
stage of glomeruli. In glomeruli at the open glomerulus stage,
the mRNA-containing cells appeared to be ring-like, and were
distributed at the periphery of the glomeruli in the area where
immature podocytes were present [11] (Fig. 1). The distribution
of hybridizing cells was closely related to that of CR! antigen at
that stage (Fig. 2). In glomeruli at the plurilobulated glomerulus
stage, the number of mRNA-containing podocytes was lower
than that of CR1-immunoreactive podocytes (data not shown).
In mature fetal glomeruli and in adult kidney sections, no
mRNA-containing cells were detected, although CR! antigen
was abundantly expressed on podocytes (Figs. 3 and 4).
Image analysis confirmed in a quantitative fashion that CR!
mRNA was significantly more abundant in immature glomeruli
than in mature fetal glomeruli and that no CR! mRNA was
detected in mature glomeruli from fetal kidneys nor in glomeruli
from adult kidneys (Fig. 5). No CR1 mRNA was present in
tubular cells in fetal and adult kidneys.
Controls
No CR! cDNA hybridization was observed in fetal kidney
sections that had been pretreated with RNase.
No hybridizing cells were detected in adult and fetal tissues
using the control plasmid probe or the renin cDNA probe.
Human tonsils served as a positive control for CR1 eDNA
hybridization. CR! cDNA-hybridizing cells in human tonsils
were distributed in the mantle zone and in the center of the
secondary follicles (Fig. 6). The distribution of CR! eDNA-
hybridizing cells correlated with that of CR1 antigen-expressing
cells.
Discussion
C3b CR! is abundantly expressed on the plasma membrane of
adult human podocytes [6, 14]. CR1 antigen is an early marker
of podocyte differentiation in human fetal kidneys [11]. In adult
podocytes, the CR! molecule is functional in that it can bind
C3b, which is attached to surfaces, and decay-dissociate pre-
formed alternative pathway C3 convertase complexes [7—141.
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Fig. 5. Quantitative image analysis ofsilver grains (grains surface per
surface unit) in CR] cDNA CR1-i-hybridized kidney sections. The
histograms depict the mean calculated surface of grains per 100 sm2 in
immature glomeruli (Im. Gb.), mature glomeruli (M. Gb.), tubules
(Tub.) and in RNase-treated (control) immature glomeruli (RNase Im.
Gb.) from two fetal kidneys (A) and in gbomeruli (Gb.) and tubules
(Tub.) from two adult kidneys (B), with 95% confidence interval.
The physiological role of CR1 on podocytes remains, however,
unclear. The present study investigated the synthesis of the
CR! protein in fetal and adult human kidney by in situ hybrid-
ization.
In fetal kidneys the CR1 mRNA-containing cells with the
CR1-l cDNA probe was detected in early stages of glomerular
maturation. Immunofluorescence and in situ hybridization stud-
ies indicated that CR1 is both expressed and actively synthe-
tized by immature podocytes. CR! mRNA expression de-
creased with the maturation of glomeruli. Thus, on the same
cryostat section of fetal kidney, CR! mRNA was present in
immature glomeruli at the open and plurilobulated stages, and
was not detected in mature (fully lobulated) glomeruli.
In adult kidney, the CR1 antigen was abundantly present on
the plasma membrane of podocytes [6, 14]. However, no CR!
mRNA was detected in the cells. The latter observation is
consistent with the lack of detectable CR1 mRNA in mature
glomeruli in fetal kidneys. The absence of CR! mRNA in
podocytes of adult kidneys was unexpected in the light of the
previous finding of CR! antigen in the endoplasmic reticulum
A Fetal kidney
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Fig. 6. In situ hybridization with the '5S CR1-i DNA probe of a human
tonsi!. Hybridizing cells are present in the germinal center (arrow) and
at the periphery of the germinal center (double arrow) (x 280).
and endocytic vesicles of adult podocytes [6, 13]. It is possible
that CR1 nRNA is present in adult podocytes in amounts that
are below the detection threshold of in situ hybridization
techniques. A long exposure of two months was required in
order to detect CR1 mRNA in fetal kidney sections, suggesting
that detectable CR! mRNA levels in the kidney are low, in
contrast with human tonsils in which a ten day exposure time
was sufficient for CR1 mRNA detection. It is also possible that
the turnover of the CR! mRNA in adult glomeruli occurs
intermittently, or alternatively, that it is very slow and that only
few CR! mRNA transcripts are sufficient to ensure the
podocyte requirement for new CR1 glycoprotein molecules.
Consistent with the latter hypothesis is the observation of a
prolonged life span of podocytes in normal rats [21]. Newly
synthetized CR1 glycoprotein would accumulate in the Golgi
apparatus and may be detected by immunoelectron micros-
copy. The mere detection of CR1 antigen on the plasma
membrane in the Golgi apparatus and in endocytic vesicles is
not indicative of ongoing synthesis of the protein, since it could
also reflect the intracellular traffic of the protein between the
plasma membrane and the Golgi apparatus [22]. In recent
studies, it was observed that specific mRNA for human elastase
was detected in cells at specific differentiation stages in the
myelocytic lineage. mRNA transcripts were absent in mature
cells of the neutrophil myeloid series although the cells con-
tained the protein [23].
Results of the present investigation indicate that the expres-
sion of the CR! gene in podocyte is tightly controlled and
differently regulated at various stages of cell differentiation.
We are currently examining whether CR1 mRNA may be
expressed in glomeruli of diseased kidneys.
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